VIROMED MEDICAL NA O.N. Total Liabilities
VIROMED MEDICAL NA O.N. total liabilities. Based on the latest financial reports, VIROMED MEDICAL NA O.N. (VME) has total liabilities worth €3.44 Million EUR (≈ $4.02 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check VIROMED MEDICAL NA O.N. (VME) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of VIROMED MEDICAL NA O.N. (2022–2025)
Total liabilities of VIROMED MEDICAL NA O.N. from 2022 to 2025. This chart illustrates how VIROMED MEDICAL NA O.N.'s total liabilities have evolved over time, based on quarterly financial data.
VIROMED MEDICAL NA O.N. Competitors by Total Liabilities
The table below lists competitors of VIROMED MEDICAL NA O.N. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Apiam Animal Health Ltd
AU:AHX
|
Australia | AU$134.72 Million |
|
Yatra Online Limited
NSE:YATRA
|
India | Rs5.06 Billion |
|
Tung Thih Electronic Co Ltd
TWO:3552
|
Taiwan | NT$6.26 Billion |
|
Kenorland Minerals Ltd
V:KLD
|
Canada | CA$8.68 Million |
|
Gabelli Global Utility & Income Tr
NYSE MKT:GLU
|
USA | $291.78K |
|
PKP Cargo S.A.
WAR:PKP
|
Poland | zł5.42 Billion |
|
INNATE PHARMA SP.ADR/1
F:IDDA
|
Germany | €84.42 Million |
|
Leap Therapeutics Inc
NASDAQ:LPTX
|
USA | $8.70 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down VIROMED MEDICAL NA O.N.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see VIROMED MEDICAL NA O.N. total assets.
Liquidity & Leverage Metrics
VIROMED MEDICAL NA O.N. Total Liabilities Ratios Explained
VIROMED MEDICAL NA O.N. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how VIROMED MEDICAL NA O.N.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for VIROMED MEDICAL NA O.N. (2022–2025)
The table below shows the annual total liabilities of VIROMED MEDICAL NA O.N. from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €3.44 Million ≈ $4.02 Million |
-16.64% |
| 2024-12-31 | €4.13 Million ≈ $4.82 Million |
+1056.85% |
| 2023-12-31 | €356.74K ≈ $417.06K |
+105.54% |
| 2022-12-31 | €173.57K ≈ $202.92K |
-- |
About VIROMED MEDICAL NA O.N.
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.